In the Press

Drug-Resistant Mold Increasingly Causing Serious Lung Infections

A new study from the U.K. has described drug-resistant lung infections in vulnerable people, raising concern that treatment options may be increasingly limited.


Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia

A new partnership to improve the resilience and profitability of Australia’s food and agribusiness industries has been kickstarted with a $34.5 million Federal Government grant announced today.


Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection

The immunological mechanisms driving susceptibility to coronavirus disease 2019 (COVID-19), a recent viral respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Zhu et al., 2020), remain elusive.


Exposure to wildfires increases risk of cancer

A new study from McGill University finds higher incidence of lung cancer and brain tumors in people exposed to wildfires. The study, which tracks over 2 million Canadians over a period of 20 years, is the first to examine how proximity to forest fires may influence cancer risk.


Overweight, obesity rose 18% in kids early in pandemic, study finds

In the first 3 to 6 months of the COVID-19 pandemic, the proportion of overweight or obese children and teens from low-income families in Ohio climbed from 38% to 45%, suggests a study presented last week at the European Congress on Obesity in the Netherlands


H5N1 avian flu now affecting more than two thirds of states

With highly pathogenic H5N1 avian flu now in Washington state and in Oregon poultry for the first time, the US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) confirms that the disease has now affected 34 US states and led to the demise of 37.55 million poultry.


Facing funding crisis, White House warns of COVID-19 surge in fall

Without a substantial infusion of cash from Congress, the United States could see another 100 million COVID-19 cases come fall, the White House warned today.


Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis

Patients with #IPF do not mount appreciable anti-spike antibody responses to two doses of #SARSCoV2 mRNA vaccine compared to the general population. National authorities should prioritise patients with IPF for booster doses.


What Makes an Office Building “Healthy”

Summary. A question on the mind of every business leader is: How do I re-populate my buildings and restart my business? As employees return to offices, the authors suggest a framework companies can deploy to keep people safe without crippling their businesses and our economy, as well as a series of health performance indicators to measure their progress.


Mucormycosis in COVID-19 pandemic: Risk factors and linkages

Mucormycosis is a serious and potentially fatal fungal infection caused by a type of rare but opportunistic fungal pathogen called mucormycetes.


none 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM others https://g.page/r/CcoVFDGYiftXEAg/review https://www.facebook.com/Healthy-Builds-West-Palm-106299645058480/reviews/?ref=page_internal